|
I.A. Kurnikova
Diabetic neuropathy: pathophysiological mechanisms and metabolic therapy
|
№12 / 2023
|
|
Ya.R. Lopatin, V.O. Tolochko, A.A. Minakov, V.V. Salukhov
The role of vaspin in the vital activities of the body
|
№3 / 2023
|
|
A.A. Grigorieva (1), L.V. Berzegova (1), K.V. Kozhina (1), E.V. Svechnikova (2)
Epi-Oral F199 – systemic anti-age therapy and antioxidant protection: ingredients
|
№8 / 2021
|
|
M.R. Orazov (1), M.B. Khamoshina (1), L.V. Pokul (1), T.N. Bebneva (1), D.I. Marapov (2), S.R. Polikarpova (3)
METABOLIC THERAPY FOR POSTHYSTERECTOMIC SYNDROME IN PERIMENOPAUSAL WOMEN
|
№12 / 2017
|
|
P.A. Khovkhaeva, N.V. Tyutyunnik, A.M. Krasny, O.A. Sergunina, L.A. Timofeeva, N.E. Kan, V.L. Tyutyunnik
OXIDATIVE STRESS AND PLACENTAL ANTIOXIDANT DEFENSE ENZYME GENES EXPRESSION IN PREECLAMPSIA
|
№3 / 2016
|
|
M.Yu. Maksimova, T.N. Fedorova, T.N. Sharypova
OXIDATIVE STRESS AND PROSPECTS OF NEUROPROTECTION IN CHRONIC CEREBROVASCULAR DISEASE
|
№10 / 2015
|
|
E.I. Chukanova, A.S. Chukanova
DISTINCT MECHANISMS OF PATHOGENESIS OF CEREBROVASCULAR INSUFFICIENCY
|
№13 / 2014
|
|
D.A. Gusakova, E.A. Efremov
PATHOGENETIC APPROACH TO THE USE OF ALPHA-LIPOIC ACID IN THE TREATMENT OF ERECTILE DYSFUNCTION IN PATIENTS WITH DIABETES MELLITUS
|
№12 / 2014
|
|
S.Yu. Kalinchenko (1), L.O. Vorslov (1), I.A. Tyuzikov (2), Yu.A. Tishova (1)
OXIDATIVE STRESS AS CAUSE OF SYSTEMIC AGING. ROLE OF A-LIPOIC ACID ( ESPA-LIPON ) IN THE TREATMENT AND PREVENTION OF AGE-ASSOCIATED DISEASES
|
№6 / 2014
|
|
A.M. Shilov
ANTIHYPOXANTS AND ANTIOXIDANTS (ACTOVEGIN) IN THE PREVENTION AND TREATMENT OF CARDIOVASCULAR COMPLICATIONS
|
№9 / 2013
|
|
I.V. Guryeva, O. V. Svetlova
Perspective Strategy In The Treatment Of Diabetic Polyneuropathy: The Role Of Antioxidant Therapy
|
№5 / 2013
|
|
N.P.Knyazheskaya
New Ultra-long-acting Beta-2-agonists In The Treatment Of Chronic Obstructive Pulmonary Disease
|
№17 / 2012
|
Русский
